Gainers: MYSZ +27%. KNDI +21%. LYL +20%. FEIM +18%. CSBR +17%. CVM +14%. BLBD +13%. VHC +12%. OXBR +13%. UBX +11%. Losers: IRIX -15%. WAB -11%. SRNE -10%. PETZ -10%. NI -10%....
CEL-SCI (NYSEMKT:CVM) has filed a prospectus for the sale of 1M shares of common stock owned by Ergomed, issued as partial payment for a Phase 3 clinical trial. The company will...
Gainers: GENE +75%. DARE +14%. TNXP +10%. CBIO +8%. MYND +7%.Losers: INNT -49%. CVM -10%. ACIU -10%. XBIO -10%. RDY -9%.Now read: Innovate: Are There Further Upsides From This...
Maxar Technologies Inc. (NYSE:MAXR) finally took out the 4-5-week channel with a pop on Wednesday of 84 cents, or 12%, to 8.01, on 3 million shares. It’s at resistance,...
ArQule, Inc. (NASDAQ:ARQL) is ramping and getting to the top of the channel, but after the breakaway gap a week ago, it’s continuing to push. On Thursday, it pushed another...
Screen Criteria: All of the Biotech companies mentioned below have have reported falling inventory turnover ratios. Average Weekly Returns: Average 1-Week Return of All Stocks...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Sell||Strong Buy||Strong Buy||Strong Buy||Strong Buy|
|Summary||Neutral||Strong Buy||Strong Buy||Strong Buy||Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Engulfing Bearish||1M||1||Oct 19|
|Engulfing Bearish||1M||6||May 19|
|Doji Star Bearish||1W||6||Sep 29, 2019|
|Engulfing Bearish||1D||6||Nov 07, 2019|
|Three Outside Up||1M||7||Apr 19|
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus and human papillomavirus co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis.Read More
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|Securities Investor Protection Corporation (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.